![Ron Chiarello](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Actieve functies van Ron Chiarello
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
54Gene, Inc.
![]() 54Gene, Inc. BiotechnologyHealth Technology 54Gene, Inc. is an American health technology company that focuses on advancing the field of genomics to improve diagnostic and treatment outcomes for diverse populations. 54Gene is a research, services, and development company located in Nigeria and the United States. The company generates genetic insights from research cohorts in diverse populations to improve the development, availability, and efficacy of therapeutics and diagnostics. The company was founded in 2019 by Dr. Abasi Ene-Obong to improve our understanding of the world's most genetically diverse population. Ron Chiarello has been the CEO of the company since 2023. | Algemeen Directeur | 15-03-2023 | - |
Loopbaan van Ron Chiarello
Eerdere bekende functies van Ron Chiarello
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Alveo Technologies, Inc.
![]() Alveo Technologies, Inc. Medical SpecialtiesHealth Technology Alveo Technologies, Inc. operates a pre-clinical stage medical diagnostics company that creates infectious disease diagnostic devices. The company was founded by Ron Chiarello, Michael A. Aicher, Lawrence M. Blatt and Sumita Pennathur in 2014 and is headquartered in Alameda, CA. | Algemeen Directeur | 01-01-2014 | 17-11-2022 |
Voorzitter | - | 17-11-2022 | |
Oprichter | 01-01-2014 | 17-11-2022 |
Statistieken
Internationaal
Verenigde Staten | 3 |
Operationeel
Chief Executive Officer | 2 |
Chairman | 1 |
Founder | 1 |
Sectoraal
Health Technology | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Alveo Technologies, Inc.
![]() Alveo Technologies, Inc. Medical SpecialtiesHealth Technology Alveo Technologies, Inc. operates a pre-clinical stage medical diagnostics company that creates infectious disease diagnostic devices. The company was founded by Ron Chiarello, Michael A. Aicher, Lawrence M. Blatt and Sumita Pennathur in 2014 and is headquartered in Alameda, CA. | Health Technology |
54Gene, Inc.
![]() 54Gene, Inc. BiotechnologyHealth Technology 54Gene, Inc. is an American health technology company that focuses on advancing the field of genomics to improve diagnostic and treatment outcomes for diverse populations. 54Gene is a research, services, and development company located in Nigeria and the United States. The company generates genetic insights from research cohorts in diverse populations to improve the development, availability, and efficacy of therapeutics and diagnostics. The company was founded in 2019 by Dr. Abasi Ene-Obong to improve our understanding of the world's most genetically diverse population. Ron Chiarello has been the CEO of the company since 2023. | Health Technology |
- Beurs
- Insiders
- Ron Chiarello
- Ervaring